AI 聊天

Polomar Health Services, Inc.

PMHS · OTC Markets OTCQB · USD

0.20 +0.00 (0.00%)

收盤價: Sep 15, 2026, 11:07 AM

市值
$5.96M

Polomar Health Services, Inc.(PMHS)股價、分析與資料

內在價值

正在載入內在價值…

分析師預測

股票預測 →

分析師預測無法取得

12個月目標價 · n/a 位分析師

分析師共識: n/a

間隔:1D
正在載入K線和訊號…

財務表現

查看財務 →

正在載入...

最新財報

已通報較預期YoY 變更
營收n/an/a
EPSn/an/a

下次財報

查看財報詳情 →

指標

買價
0.17
市值
5.96M
淨利(ttm)
-9.55M
n/a
-0.35
n/a
n/a
P/B (ttm)
-5.68
P/S (ttm)
1.88
財報日期
n/a
賣價
0.3
成交量
5,000
20 日平均成交量
3,244
開盤價
0.21
前收盤價
0.20
當日區間
0.21 - 0.21
52 週範圍
0.07 - 0.80
股利
n/a
除息日
n/a
還沒有可用的新聞文章

關於 Polomar Health Services, Inc.

查看公司資料 →
Polomar Health Services, Inc. operates as a retail compounding pharmacy in the United States. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; Tofacitinib, it treats rheumatoid arthritis by inhibiting JAK to reduce inflammation and pain; Semaglutide GLP-1, which regulates blood sugar, appetite, and weight in diabetes management; and compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker's nevus, vitiligo, and other skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California. Pharmaceutical Retailers · Healthcare

Polomar Health Services, Inc. operates as a retail compounding pharmacy in the United States. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; Tofacitinib, it treats rheumatoid arthritis by inhibiting JAK to reduce inflammation and pain; Semaglutide GLP-1, which regulates blood sugar, appetite, and weight in diabetes management; and compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker's nevus, vitiligo, and other skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.

類股 Healthcare
IPO 日期 Feb 9, 2009
員工 6
證券交易所 OTC Markets OTCQB
股票代號 PMHS